HIGHLIGHTS FROM THE 25TH CONGRESS OF THE EUROPEAN COMMITTEE FOR TREATMENT AND RESEARCH IN MULTIPLE SCLEROSIS (ECTRIMS)

被引：0
|
作者：
Rabasseda, Xavier [1 ]
机构：
[1] Thomson Reuters, Dept Med, Barcelona, Spain
来源：
DRUGS OF TODAY | 2010年 / 46卷 / 01期
关键词：
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PLACEBO-CONTROLLED CLARITY; ORAL FINGOLIMOD FTY720; SUBCUTANEOUS INTERFERON BETA-1A; STEM-CELL TRANSPLANTATION; QUALITY-OF-LIFE; INDUCED DEMYELINATING DISEASE; CLINICALLY ISOLATED SYNDROME; LONG-TERM TREATMENT; 12-MONTH PHASE-III;
D O I：
10.1358/dot.2010.46.1.1459657
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
The Rhine river was the scenario of this year's congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS), held in the Dusseldorf Messe right beside the river in September 9-12, 2009. The meeting contained a number of important new contributions with a direct impact in how patients are and can be treated in the current clinical setting.
引用
收藏
页码：49 / 67
页数：19
相关论文
共 50 条
12345